In adults with obesity or overweight and knee osteoarthritis, retatrutide at 12 mg produced 23.7% body weight loss (an average of 60 pounds) compared to 4.6% with placebo over a full treatment period
For meal inspiration, check out GLP-1 breakfast ideas and dinner ideas designed specifically for people on these medications
Social media clips and discussion forums may surface news quickly, but they can also blur the difference between trial data, regulatory approval, and market access
Journal of the American Heart Association , 9 (21), e016828
(a Chinese export company) NDC: 84778-108 Marketing status: Export only Marketing start date: October 29, 2025 Not manufactured by Eli Lilly Not FDA-approved for use in the United States The DailyMed entry ranks second organically for "retatrutide pen" searches, which is why so many users encounter it and assume it represents a legitimate commercial product
Excellent, well informed doctors who help you